Literature DB >> 15837026

Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers.

E Reed Smith1, Wendy Klein-Schwartz.   

Abstract

Ingestion of 1-2 tablets of chloroquine or hydroxylchloroquine is thought to predispose children under 6 years of age to serious morbidity and mortality. The actual risk to the toddler and appropriate guidelines for care remain unclear at a time when both medications are therapeutically utilized as anti-inflammatory agents in addition to their main use as anti-parasitics. A review of the literature and data from the American Association of Poison Control Centers reveals instances where exposure to as little as 1-2 tablets of chloroquine resulted in serious consequences. Based on these findings, ingestions of greater than 10 mg/kg of chloroquine base or unknown amounts require triage to the nearest health care facility for 4-6 h of observation. There is very limited data on pediatric hydroxychloroquine overdoses and no reports of toxicity from 1-2 pills, but given its similarity to chloroquine, it also should be considered potentially toxic at small doses. Thus, similar recommendations should be followed for triage after accidental hydroxychloroquine overdose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837026     DOI: 10.1016/j.jemermed.2004.12.011

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  19 in total

1.  STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

Authors:  S Kuhn; C Hui
Journal:  Can Commun Dis Rep       Date:  2010-06-10

2.  Toxicology case of the month: ingestion of two unidentified tablets by a toddler.

Authors:  D McCoubrie; L Murray; F F S Daly; M Little
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

3.  Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Daniel Blessborn; Rikke Thoft-Nielsen; Anders Björkman; Lars Rombo
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 4.  Principles and current strategies for targeting autophagy for cancer treatment.

Authors:  Ravi K Amaravadi; Jennifer Lippincott-Schwartz; Xiao-Ming Yin; William A Weiss; Naoko Takebe; William Timmer; Robert S DiPaola; Michael T Lotze; Eileen White
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

5.  Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Yngve Bergqvist; Lars Rombo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

6.  Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis.

Authors:  Qinghong Wang; Jijun Zhou; Bei Zhang; Zhiqiang Tian; Jun Tang; Yanhua Zheng; Zemin Huang; Yi Tian; Zhengcai Jia; Yan Tang; Jennifer C van Velkinburgh; Qing Mao; Xiuwu Bian; Yifang Ping; Bing Ni; Yuzhang Wu
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

7.  Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies.

Authors:  Anthony J Garcia-Prats; Nicole Salazar-Austin; James H Conway; Kendra Radtke; Sylvia M LaCourse; Elizabeth Maleche-Obimbo; Anneke C Hesseling; Rada M Savic; Sharon Nachman
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

8.  Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations.

Authors:  Vangelis Karalis; George Ismailos; Eleni Karatza
Journal:  Saf Sci       Date:  2020-05-21       Impact factor: 4.877

9.  Chloroquine is grossly under dosed in young children with malaria: implications for drug resistance.

Authors:  Johan Ursing; Staffan Eksborg; Lars Rombo; Yngve Bergqvist; Daniel Blessborn; Amabelia Rodrigues; Poul-Erik Kofoed
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Authors:  Myrna R Rosenfeld; Xiaobu Ye; Jeffrey G Supko; Serena Desideri; Stuart A Grossman; Steven Brem; Tom Mikkelson; Daniel Wang; Yunyoung C Chang; Janice Hu; Quentin McAfee; Joy Fisher; Andrea B Troxel; Shengfu Piao; Daniel F Heitjan; Kay-See Tan; Laura Pontiggia; Peter J O'Dwyer; Lisa E Davis; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.